Pancreatic Size is Reduced in Recent Onset Type 1 Diabetes in Young Children

This abstract has open access
Abstract Summary

Background

Adults with type 1 diabetes (T1D) have smaller pancreata and there is growing evidence for accompanying immune infiltrates in the exocrine pancreas and subclinical exocrine dysfunction. Beta cells comprise 200 ug/g.

Conclusion

Pancreatic area in transverse and longitudinal planes is reduced in young children within the first week of clinical onset of T1D. This finding supports the involvement of the exocrine pancreas in the pathophysiology of T1D in early life.

Submission ID :
IDS27127
Submission Type
Poster
Abstract Topics
Poster Session C
Dr Priya Augustine
Women's and Children's Hospital, Adelaide, South Australia
Professor Jenny Couper
Robinson Research Institute, University of Adelaide , Australia
Dr Jennie Louise
The Robinson Research Institute, University of Adelaide, Australia
Dr Megan Penno
Robinson Research Institute, University of Adelaide , Australia
Mr Roger Gent
Department of Medical Imaging, Women's and Children's Hospital, Australia
Mr Mario Taranto
PathWest, Fiona Stanley Health Network, Australia
Dr Rebecca Linke
Department of Medical Imaging, Women's and Children's Hospital, Australia

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
IDS5710
A Llama Nanobody VHH format with beta-cell IC2 autoantibody specificity created by an anti-idiotypic immunization.
Poster Session C
Poster
Miss Liis Pärnpuu
IDS34154
A luciferase-based immunoprecipitation system assay for IAA using Nluc-proinsulin shows improved discrimination of diabetes risk in children and young adults
Poster Session C
Poster
Dr Rebecca Wyatt
IDS59192
A methylation-sensitive multiplex droplet digital PCR assay to quantify beta-cell destruction in type 1 diabetes
Poster Session C
Poster
Miss Fatma Al Rashidi
IDS2348
A novel highly specific and sensitive mAb against capsid protein VP1 to study the involvement of Enteroviruses in type 1 diabetes.
Poster Session B
Poster
Klaus-Peter Knoch
IDS62158
A targeted, high affinity TCR based therapy for the treatment of Type I Diabetes
Poster Session B
Poster
Dr Giovanna Bossi
IDS589
Activated human mesenchymal stromal cells process and present islet peptides inducing adaptive immune regulation of islet autoimmunity
Poster Session A
Poster
Dr Kayleigh Van Megen
IDS1519
Addition of Metformin to Insulin on the Decline Rate of β-cell Function in Non-obese Patients with Latent Autoimmune Diabetes in Adults: A Three-year Open-labeled Pilot Study
Poster Session B
Poster
Dr Xia Li
IDS23213
Altered gene signature for ER stress, metabolism and apoptosis precedes immune activation in pancreas and suggests a hepatic clue to diabetogenesis
Poster Session A
Poster
Dr Daniel Serrano
IDS52118
Altered gut microbiota activate and expand insulin B15-23-reactive CD8+ T-cells
Poster Session B
Poster
Dr James Pearson
3 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org